James B. Hawkins - Dec 7, 2025 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ James B. Hawkins
Stock symbol
IRMD
Transactions as of
Dec 7, 2025
Transactions value $
$0
Form type
4
Date filed
12/9/2025, 05:00 PM
Previous filing
Nov 24, 2025
Next filing
Dec 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAWKINS JAMES B Director C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO /s/ James B. Hawkins 2025-12-09 0000898243

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +1.2K +3.92% 31.7K Dec 7, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -1.2K -100% $0.00 0 Dec 7, 2025 Common Stock 1.2K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.